According to Glenmark Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 3.09.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.47 | 108.59% |
2022-12-31 | 1.19 | -28.3% |
2021-12-31 | 1.65 | -23.57% |
2020-12-31 | 2.16 | 31.6% |
2019-12-31 | 1.64 | -52.08% |
2018-12-31 | 3.43 | 9.28% |
2017-12-31 | 3.14 | -39.86% |
2016-12-31 | 5.22 | -17.17% |
2015-12-31 | 6.30 | -2.62% |
2014-12-31 | 6.47 | 26.71% |
2013-12-31 | 5.11 | -6.61% |
2012-12-31 | 5.47 |